Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of 781,126. The enterprise value is 10.11 million.
| Market Cap | 781,126 |
| Enterprise Value | 10.11M |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 1.77 million shares outstanding. The number of shares has increased by 12.03% in one year.
| Current Share Class | 1.77M |
| Shares Outstanding | 1.77M |
| Shares Change (YoY) | +12.03% |
| Shares Change (QoQ) | +31.08% |
| Owned by Insiders (%) | 62.89% |
| Owned by Institutions (%) | 6.15% |
| Float | 365,689 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.30 |
| PB Ratio | -0.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.31 |
| EV / Sales | 16.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.30 |
Financial Position
The company has a current ratio of 2.43
| Current Ratio | 2.43 |
| Quick Ratio | 2.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.92 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -404.48% and return on invested capital (ROIC) is -48.81%.
| Return on Equity (ROE) | -404.48% |
| Return on Assets (ROA) | -33.08% |
| Return on Invested Capital (ROIC) | -48.81% |
| Return on Capital Employed (ROCE) | -94.68% |
| Weighted Average Cost of Capital (WACC) | 0.11% |
| Revenue Per Employee | 20,000 |
| Profits Per Employee | -1.10M |
| Employee Count | 30 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid 15,000 in taxes.
| Income Tax | 15,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.67% in the last 52 weeks. The beta is 0.05, so LYRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -94.67% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 5.91 |
| Relative Strength Index (RSI) | 21.04 |
| Average Volume (20 Days) | 142,094 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.16 |
Income Statement
In the last 12 months, LYRA had revenue of 600,000 and -32.95 million in losses. Loss per share was -22.93.
| Revenue | 600,000 |
| Gross Profit | -19.80M |
| Operating Income | -32.41M |
| Pretax Income | -32.93M |
| Net Income | -32.95M |
| EBITDA | -31.90M |
| EBIT | -32.41M |
| Loss Per Share | -22.93 |
Balance Sheet
The company has 22.06 million in cash and 31.38 million in debt, with a net cash position of -9.32 million or -5.25 per share.
| Cash & Cash Equivalents | 22.06M |
| Total Debt | 31.38M |
| Net Cash | -9.32M |
| Net Cash Per Share | -5.25 |
| Equity (Book Value) | -4.33M |
| Book Value Per Share | -2.63 |
| Working Capital | 13.54M |
Cash Flow
In the last 12 months, operating cash flow was -34.15 million and capital expenditures 38,000, giving a free cash flow of -34.11 million.
| Operating Cash Flow | -34.15M |
| Capital Expenditures | 38,000 |
| Free Cash Flow | -34.11M |
| FCF Per Share | -19.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | -5,401.33% |
| Pretax Margin | -5,488.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.03% |
| Shareholder Yield | -12.03% |
| Earnings Yield | -4,217.89% |
| FCF Yield | -4,366.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2025. It was a reverse split with a ratio of 0.02.
| Last Split Date | May 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
LYRA has an Altman Z-Score of -15.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.58 |
| Piotroski F-Score | n/a |